Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry

informCLL is the first United States-based registry of patients with chronic lymphocytic leukemia that initiated enrollment after approval of novel targeted agents. Prognostic/predictive testing rates and chronic lymphocytic leukemia treatment selection with availability of novel agents have not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Mato, Anthony R., Barrientos, Jacqueline C., Ghosh, Nilanjan, Pagel, John M., Brander, Danielle M., Gutierrez, Meghan, Kadish, Karen, Tomlinson, Brian, Iyengar, Reethi, Ipe, David, Upasani, Sandhya, Amaya-Chanaga, Carlos I., Sundaram, Murali, Han, Jennifer, Giafis, Nick, Sharman, Jeff P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890939/
https://www.ncbi.nlm.nih.gov/pubmed/32033927
http://dx.doi.org/10.1016/j.clml.2019.10.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890939/
https://www.ncbi.nlm.nih.gov/pubmed/32033927
http://dx.doi.org/10.1016/j.clml.2019.10.009

Ejemplares similares